Toronto Gestational Glucose Tolerance Cohort
Launched by MOUNT SINAI HOSPITAL, CANADA · Oct 20, 2015
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
The Toronto Gestational Glucose Tolerance Cohort is a clinical trial that is studying how different levels of blood sugar during pregnancy can affect women's health in the years after they give birth. The researchers are focusing on women who have had varying experiences with blood sugar, including those who might develop conditions like Type 2 diabetes or pre-diabetes later on. The trial is currently recruiting participants, specifically pregnant women aged between 7304 to 21914 days (which means they should be between about 20 to 60 years old). However, women who already had diabetes before becoming pregnant cannot participate.
If you choose to join this study, you will be regularly monitored over a number of years after your pregnancy. This means the researchers will check your health and how your body is handling sugar levels at different times. By participating, you will help contribute to important knowledge that may improve care for women with similar conditions in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women
- Exclusion Criteria:
- • Pre-existing diabetes before the index pregnancy
About Mount Sinai Hospital, Canada
Mount Sinai Hospital, located in Canada, is a leading academic health institution renowned for its commitment to innovative research and high-quality patient care. As a sponsor of clinical trials, Mount Sinai Hospital leverages its extensive expertise in various medical disciplines to advance clinical knowledge and develop new therapies. The hospital collaborates with a diverse network of healthcare professionals, researchers, and institutions to conduct rigorous trials that aim to improve health outcomes and enhance the quality of life for patients. With a focus on ethical standards and patient safety, Mount Sinai Hospital is dedicated to translating scientific discoveries into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Ravi Retnakaran, MD
Principal Investigator
MOUNT SINAI HOSPITAL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials